12:00 AM
 | 
Jan 02, 2012
 |  BC Week In Review  |  Company News  |  Deals

Karo Bio, Pfizer deal

Karo partnered with Pfizer to discover and develop small molecule RAR-related orphan receptor C ( RORC; RORgamma;

Read the full 87 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >